AI in Oncology

Christopher Merlan, MS
ASCO's Chief Digital Officer

CNE Available!

The era of Artificial Intelligence in oncology is no longer a future prospect—it is a clinical reality. Join ASCO EVP and Chief Digital Officer Christopher R. Merlan to explore how AI is moving beyond the hype to transform daily practice. This session examines real-world applications—from ambient listening tools that reduce clinician burnout to LLMs that streamline clinical trial matching. You will also gain an inside look at ASCO’s Guiding Principles for AI, a framework designed to ensure transparency, accountability, and patient-centric care. Discover how to navigate the evolving AI landscape and leverage these tools to augment your expertise and amplify your impact on patient outcomes.

Christopher R. Merlan is Chief Digital Officer and Executive Vice President at ASCO, bringing over 25 years of experience leading digital transformation initiatives with a focus on the strategic application of AI. He co-led ASCO's Board Task Force on AI in Oncology Care, a pivotal initiative that established guiding principles for oncologists navigating the complexities of AI integration, ensuring ethical considerations and patient well-being remain paramount. A passionate advocate for responsible AI adoption, Chris continues to spearhead efforts that leverage technology to address complex challenges in oncology care and improve outcomes for patients.

This nursing continuing professional development activity was approved by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Overview of Immune Related Adverse Events Caused by Immune Checkpoint Inhibition* - presented by Bristol Myers Squibb

Greg Norigian, PharmD

*open to medical professionals only